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Abstract
By employing information theoretic measures, this study presents a structure and functional analysis of a multidrug-proton
antiporter Mdr1p of Candida albicans. Since CaMdr1p belongs to drug-proton antiporter (DHA1) family of Major Facilitator
Superfamily (MFS) of transporters, we contrasted DHA1 (antiporters) with Sugar Porter family (symporters). Cumulative
Relative Entropy (CRE) calculated for these two sets of alignments enabled us to selectively identify conserved residues of
not only CaMdr1p but for the entire DHA1 family. Based on CRE, the highest scoring thirty positions were selected and
predicted to impart functional specificity to CaMdr1p as well as to other drug-proton antiporters. Nineteen positions
wherein the CaMdr1p residue matched with the most frequent amino acid at a particular alignment position of DHA1
members were subjected to site-directed mutagenesis and were replaced with either alanine or leucine. All these mutant
variants, except one, displayed either complete or selective sensitivity to the tested drugs. The enhanced susceptibility of
these mutant variants was corroborated with the simultaneously abrogated efflux of substrates. Taken together, based on
scaled CRE between two MFS sub-families, we could accurately predict the functionally relevant residues of CaMdr1p. An
extrapolation of these predictions to the entire DHA1 family members as validated from previously published data shows
that these residues are functionally critical in other members of the DHA1 family also.
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Introduction
The azoles are a major class of drugs used to treat many fungal
infections, and although they have good pharmacokinetic properties
and are well tolerated, several fungi including pathogenic Candida
albicans show innate or acquired azole resistance. A significant
mechanism of azole resistance includes an over-expression of
membrane proteins that actively efflux the incoming drugs [1].
Among the 28 putative ATP-Binding Cassette (ABC) transporter
genes and 95 putative Major Facilitator Superfamily (MFS)
transporter genes identified in the C. albicans genome, only CaCdr1p
and CaCdr2p among the ABC transporters and CaMdr1p among
the MFS transporters are multidrug transporters involved in
clinically encountered azole resistance of this fungal pathogen.
Thus, azole resistant clinical isolates mostly show an increased
expression of the plasma membrane efflux pumps encoding genes,
viz. CaCDR1, CaCDR2 and CaMDR1 [2], [3].
Studies in the major ABC transporters of C. albicans such as
Cdr1p, Cdr2p have revealed that these transporters harbor
multiple drug binding sites which are scattered within TMDs
[4]. Notwithstanding similar topology and promiscuity towards
substrates specificity, these ABC multidrug transporters of Candida
also display selectivity to the range of substrates they export [5]. In
comparison to ABC transporters, the structural and functional
aspects of MFS multidrug transporters are only beginning to
emerge. MFS is one of the largest families of transporters and
includes members that function as uniporters, symporters or
antiporters. Structural studies of MFS transporters revealed that
the members of this superfamily share structural homology but
have relatively weak sequence similarities. MFS transporters are
an important superfamily of membrane proteins which import or
export diverse substrates and catalyze different modes of transport
using unique combinations of functional residues [6]. The
structural studies conducted so far suggest the possibility that the
fold of these transporters constitutes a scaffold for all MFS
members with 12 helices. Although the fold is conserved, the
specific function is obtained by varying sets of amino acids at the
substrate binding and translocation domains. This is quite evident
from the structural differences between Lactose Permease (LacY)
of E.coli (symporter) and Glycerol-3-Phosphate (GlpT) of E.coli
(antiporter) [7]. Very recently, we identified residues important for
the entire MFS family irrespective of its mechanism of transport.
However, our method did not identify subfamily function-specific
residues [8].
Predicting functionally important residues from a Multiple
Sequence Alignment (MSA) by using the criteria of amino acid
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conservation and then employing site-directed mutagenesis for
validation has been a common approach. Multiple methods for
scoring the amino acid conservation are being used frequently [9].
However, this process has serious limitations, particularly since the
criterion of conservation across the sequence alignment, does not
necessarily predict the functional importance of a residue for a
given protein. A residue shown to be conserved across MSA can
be important for the entire class and can have a role in
maintaining the fold of the protein rather than playing a more
specific role in its function [8]. Moreover, if a dataset has a
significant number of recently evolved sequences, the conservation
score of the alignment columns picked up as conserved might be
an erroneous representation of the data set.
The neutral theory of molecular evolution states that once a
protein has evolved to a useful level of functionality the majority of
mutations are selectively neutral at the molecular level and do not
affect the function and folding of the protein whereas those
mutations which are deleterious (loss of function or misfolding)
provide selection pressure for residue conservation [10]. Thus, the
residue conservation in a multiple alignment of a protein and its
homologues indicates the importance of the residue for maintain-
ing the structure and function of the protein. Claude Shannon
founded information theory in 1940s and this theory has long been
known to be closely related to thermodynamics and physics [11].
In 1991, Sander and Schneider used Shannon entropy
derived scores for positional conservation in alignment of proteins
[12].
The commonly used and well known information theoretic
scores are entropy (H) and relative entropy (RE). The entropy
score for each aligned column in a MSA can be expressed as:
Hi~{
X
for all x
pi xð Þlogpi xð Þ
where P(xi) is the probability of finding amino acid type x at
aligned column i.
The entropy value is maximum for an alignment column having
randomly distributed amino acids while it is zero for a completely
conserved column.
Relative entropy is the measure of divergence between the two
probability distributions of residues. This calculates conservation
of aligned column over background probability distribution.
REpIIq~
X
for all x
pi xð Þlog pi xð Þ
q xð Þ
where q(x) is the background probability of amino acid type x.
Background probability means the probability of occurrence of
a particular amino acid in nature (calculated from protein
sequence database, Swissprot) [13]. Often, the mutational changes
at particular conservation site after the gene duplication leads to
functional divergence [14]. The residues of a protein at these sites
are called specificity determining residues (SDR) which when
mutated lead to changes in the protein’s function. The information
theoretical methods have been increasingly applied in bioinfor-
matics to identify such SDRs [11], [15], [16]. Given an alignment,
and a set of proteins grouped into sub-families, according to some
definition of function, such as catalytic activity, the method
identifies positions that are indicative of these functional
differences between the mentioned sub-families [9]. In view of
this, we used information theoretic measure, scaled cumulative RE
(CRES) in preference to traditional conservation measures [16], to
predict residues important for DHA1 family of which CaMdr1p is
a member, and extrapolated it to other members of its family. In
this manuscript, we contrast DHA1; a family of drug-proton
antiporters, with Sugar Porter (SP); a family of symporters to
predict the residues important for a drug-proton antiporter
exclusively, on the basis of CRES. We selected thirty residues
with highest CRES for analysis. Selected residues were subjected to
site-directed mutagenesis and replaced with alanines or leucines.
Notably, the mutant variants of these residues showed abrogation
of resistance to either all or to selected drugs. The enhanced
susceptibility of these mutant variants to the drugs was
corroborated with abrogated efflux of the substrates. From
previously published data, we validated our predictions by
showing that the equipositional residues in other members of the
DHA1 family are also functionally critical. Our study shows that
the use of CRES provides an impartial score to select differentially
conserved residues, which can be evaluated for their functional
significance.
Results
CRES scores predict functionally important residues of
CaMdr1p
We attempted to rationalize the site-directed mutational
strategy in order to predict functionally critical residues of
CaMdr1p. As CaMdr1p belongs to DHA1 family; a family of
drug-proton antiporters, we contrasted its sequences with another
family of MFS transporters having totally different function. For
this sort of comparison, SP family; a family of symporters was
chosen as it completely differs from DHA1 in terms of mechanism
of transport as well as its substrate specificity. Upon alignment of
sequences from these two families, it was hypothesized that those
residues which are exclusively conserved or are differentially
conserved in DHA1 will be critical for DHA1-specific function.
We speculated that such a contrast will predict residues exclusively
important for DHA1 family. The dataset included 37 of DHA1
and 44 of SP sequences with no redundancy. Other such
contrasting families of MFS have very few members and were
not included since the use of smaller dataset is prone to statistical
errors.
We then employed a well-known information theoretic
measure, CRE, with this comprehensive non-redundant dataset.
The complete alignment in clustalw format is shown in
Supplementary Data S1. The RE within a family (conservation
across a subfamily) and CRES scores across all columns of this
profile MSA were calculated Supplementary Data S2. Figure 1
shows a representative part of this profile alignment with
Cumulative Relative Entropy (CRES), Relative Entropy (RE)
and conservation scores for each alignment position. We predicted
that for a residue to be functionally critical, it should not only have
a high CRE score but should also be highly conserved in the
DHA1 family. Thus, a criterion of selection which took both the
conservation score and the CRE score in consideration was
required. For this, a scaled CRE score (CRES), a product of
conservation across only DHA1 (measured using RENULL), and
CRE between the two families were calculated. A residue position
with high CRES was predicted to be either differentially conserved
across the two families or exclusively conserved in the DHA1
family vis-a`-vis the SP family and thus was predicted to impart
functional specificity to DHA1. The distribution curve generated
on the basis of CRES scores of the entire MSA is shown in
Figure 2A. The thirty residues with highest CRES were shortlisted
for further studies. The range of selection spanned from a scaled
score of 6.12-1.96 and is highlighted in Figure 2A.
Critical Residues of CaMdr1p
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T L V V F R I V G G I G V G V A S V I A P A Y I A E T S P P - G I R G R L G S L Q Q L A I V L G I F T S F V V N W L
D L A M W R I I G G F A I G M A S V I G P A Y I A E V S P P - A Y R G R L G S F Q Q A A I V I G I A V S Q L V N W G
D F I F W R V L G G I G V G A A S V I A P A Y I A E V S P A - H L R G R L G S L Q Q L A I V S G I F I A L L S N W F
V L I S G R L L V G L G V G V A S V T A P V Y I A E A S P S - E V R G G L V S T N V L M I T G G Q F L S Y L V N S A
L L V V G R V F V G L G V G M A S M T A P L Y I S E A S P A - K I R G A L V S T N G F L I T G G Q F L S Y L I N L A
T L L A G R L V V G L G I G I A S M T V P V Y I A E V S P P - N L R G R L V T I N T L F I T G G Q F F A S V V D G A
T L I I A R I I G G L G I G M G S S L S V T Y I T E A A P P - A I R G S L S S L Y Q L F T I L G I S A T Y F I N L A
V M V V G R V L L G L A V G G A S T V V P V Y L A E L A P F - E I R G S L A G R N E L M I V V G Q L A A F V I N A I
V M I I S R F V L G I A V G G A S V T V P A Y L A E M S P V - E S R G R M V T Q N E L M I V S G Q L L A F V F N A I
M L I A A R V V L G I A V G I A S Y T A P L Y L S E M A S E - N V R G K M I S M Y Q L M V T L G I V L A F L S D T A
V L I L S R V L L G L A V G V A S Y T A P L Y L S E I A P E - K I R G S M I S M Y Q L M I T I G I L G A Y L S D T A
S T F I A F L L I S F G Y N F V I T A G N A M I I D A S N A - E N R K V V F M L D Y W A Q N L S V I L G A A L G A W
W I L I I R L L Q G A F A G F L V A M Q T Y A L S - I T E W - Q N K S T Q L S R L Q S S K A I A T S T A G F L G G L
L L W F S C L L S G L G G T L F D P P R S A L V V K L I R P - Q Q R G R F F S L L M M Q D S A G A V I G A L L G S W
V L V A C R V V A A L A N A G F L A V A L T T A A A L V P A - D K Q G R A L A V L L S G T T V A T V A G V P G G S L
L F L A G R F L Q G L G A G C C Y V V A F A I L R D T L D D - R R R A K V L S L L N G I T C I I P V L A P V L G H L
V L I A A S A M Q G M G T G V G G V M A R T L P R D L Y E R - T Q L R H A N S L L N M G I L V S P L L A P L I G G L
W Y F A M I S V S G V F S V T F - S V I F A Y V A D V T Q E - H E R S T A Y G W V S A T F A A S L V S S P A I G A Y
T L F A A R S L Q G L G S A F A D T S G I A M I A D K Y P E E P E R S R A L G V A L A F I S F G S L V A P P F G G I
F L L I A R S L Q G I G S S C S S V A G M G M L A S V Y T D D E E R G N V M G I A L G G L A M G V L V G P P F G S V
L L F V A R T L Q G I G S S F S S V A G L G M L A S V Y T D D H E R G R A M G T A L G G L A L G L L V G A P F G S V
L L F V A R T L Q G I G S S F S S V A G L G M L A S V Y T D N Y E R G R A M G I A L G G L A L G L L V G A P F G S V
L L L I G R A C L G L A L G G F W A M S A S L T M R L V P P - R T V P K A L S V I F G A V S I A L V I A A P L G S F
T L M V S R V L A A M S T G L I V V L S L T I A P K I V A P - E Y R A R A I G I I F M G F S S A I A L G V P L G I L
V L V I S R A G V A L A H S V F W S I T A S L A I R M A P P - G K R A Q A L G L I A T G S S L A M V L G L P L G R V
V L V I S R I G V A F A H A I F W S I T A S L A I R M A P A - G K R A Q A L S L I A T G T A L A M V L G L P L G R I
M L A I G R L V S G F P H G A F F G V G A I V L S K I I K P - G K V T A A V A G M V S G M T V A N L L G I P L G T Y
Q F T L L R F L Q G I S L C F I G A V G Y A A I Q E S F E E - A V C I K I T A L M A N V A L I A P L L G P L V G A A
W L L A A R A L Q G L S A G A G V V V G Q A I I R D C Y Q G - A A A Q R S M S Y L I L V F N L S P A L A P V I G G Q
Q L I V M R F F H G L A A A A A S V V I N A L M R D I Y P K - E E F S R M M S F V M L V T T I A P L M A P I V G G W
W L I F L R L L N G V F A G F V - P N A T A L I A S Q V P K - E K S G S A L G T L S T G V V A G T L T G P F I G G F
Q F L I L R A L L G L L G G F V - P N A N A L I A T Q V P R - N K S G W A L G T L S T G G V S G A L L G P M A G G L
Q I L L L R G I A G I G S T M F T V S A M G L I V K M A P V - E I R G R C S S V Y A S S F L F G N I I G P V V G A A
V L M L S R V I G G M S A G M V M P G V T G L I A D I S P S - H Q K A K N F G Y M S A I I N S G F I L G P G I G G F
I F Y F S R I L G G V S A A F I M P A V T A Y V A D I T T L - K E R S K A M G Y V S A A I S T G F I I G P G A G G F
V L V L A R V I Q G L T A G D L - P A L F A Y L A D I T P P - E Q R A K R F G L L G A L S G I G T M I G P A I G G L
W L Y L G R L L A G I T G A N M - A V A T A Y V T D I T P V - G Q R A R R F G L V G A V F G V G F I V G P L L G G S
W L Y I G R I F A G I T G A N M - A V A T A Y V S D I T P A - H E R A K R F G L L G A V F G I G F I A G P V I G G V
V L Y I G R I V A G I T G A T G - A V A G A Y I A D I T D G - D E R A R H F G F M S A C F G F G M V A G P V L G G L
V F L G L R I L Q A C G A S A C L V S T F A T V R D I Y A G R E E S N V I Y G I L G S M L A M V P A V G P L L G A L
Q I I V L R C L Q A A G I S P V I A I N S G I M G D V T T R - A E R G G Y V G Y V A G F Q V L G S A F G A L I G A G
A L F V L R I F Q A F A S S S V I S L G A G T V T D V V P P - K H R G K A I A Y F M M G P N M G P I I A P I V A G L
T I F I C R F F G G F I G A A P M A V V P A A F A D M F D T - N V R G K A I A L F S L G V F V G P I L S P V M G S Y
V L L P M R F L A G F F G S P A L A T G G A T L A D I W Q P - W L L P Y F M C F W A I G A I G G P V L G P L L G G A
G L I V M R F I S G I L C S P S L A T G G G T V A D I I S P - E M V P L V L G M W S A G A V A A P V L A P L L G A A
G L C I L R F L G G F F A S P C L A T G G A S V A D V V K F - W N L P V G L A A W S L G A V C G P S F G P F F G S I
G L S V L R V I A G F F A A P A L S T G G A S Y G D F I A M - H Y Y S I A L G V W S I F A V A G P S I G P L I G A A
Q M I I S H F I I G V A G S T A L T N V A G G I P D L F P E - D T A G V P M S L F V W A C A G G A I G A P M A T G V
Figure 1. Representative alignment of MFS sequences. Figure showing a representative portion of the Multiple Sequence Alignment of the
MFS sequences and is generated using Alscript [31]. The top 37 sequences which are boxed belong to the DHA1 family and the next 44 belong to the
SP family. The part of the MSA spanning helix 4 and 5 is highlighted in the figure. Alignment columns are coloured in a gradient based on the degree
of conservation. TCDB ID of CaMdr1p Sequence is 2.A.1.2.6 and is third from the top. The complete MSA is shown in Supplementary Data DS1. Green
columns denote family-wide conservation, while conserved columns in DHA1 and SP family are coloured in blue and yellow respectively. A
comparison of conservation, RE and CRES scores are shown as histograms [28]. CRES identifies columns which are differentially conserved in the DHA1
family. The phenotypes of the mutated positions in CaMdr1p are indicated by triangles, red being sensitive and pink being differential.
doi:10.1371/journal.pone.0011041.g001
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Site-specific mutagenesis confirms CRES based selection
of functionally critical residues
Nineteen out of the thirty highest CRES alignment positions had
the most frequent amino acid matching with the CaMdr1p residue.
These are enlisted in Figure 2B and include D235, G264, P261,
G133, A231, G472, V364, Y369, G391, G515, M132, F277, P139,
L246, P512, S232, S505, P257 and V496. These residues which
were predicted to be functionally relevant were subjected to site-
directed mutagenesis and were replaced with alanine. In the cases
where glycines were present, they were replaced with leucine while
the existing alanines were replaced with glycines. For functional
analysis of the mutant variants, we used a heterologous hyper-
expression system, where GFP-tagged CaMdr1p (CaMDR1-GFP)
was stably over-expressed from a genomic PDR5 locus in AD1-8u-, a
S. cerevisiae mutant. The host AD1-8u- developed by Goffeau’s
group, was derived from a Pdr1-3 mutant strain with a gain-of-
function mutation in the transcription factor Pdr1p, resulting in
constitutive hyper-induction of the PDR5 promoter. A single-copy
integration of each transformant at the PDR5 locus was confirmed
by Southern hybridization (data not shown). Two positive clones of
each mutant were selected to rule out clonal variations.
The mutant variants of CaMdr1p were analyzed for their drug
susceptibility by employing microtiter plate and spot assays. All the
high CRES residues except P139A showed decreased resistance to
tested drugs. Though all the cells expressing mutant variant
CaMdr1p, grew poorly on solid as well as in liquid media, a closer
look revealed the variation in specificity of these residues to drugs
and their magnitude of resistance. On the basis of selective
sensitivity to various drugs, these mutant variants could be
grouped into three classes. Class I included the mutant variants
such as D235A, G264L, G133L, G472L, Y369A, G391L, G515L,
F277A and S232A which displayed sensitivity towards all the
drugs. Notably, P261A, L246A and P257A belong to antiporter
motif which also bunched within this class. The residues which
showed selective increase in sensitivity towards the considered
spectrum of drugs were grouped in Class II. The six mutant
variants A231G, M132A, P512A, V496A, S505A and V364A of
this class showed selective decrease in resistance at differential
levels for various drugs. For example, mutant variants A231G,
M132A, P512A and V496A continued to display resistance to
FLU, MTX, ANISO, CER but exhibited sensitivity towards CYH
and 4-NQO. S505A was susceptible to ANISO along with CYH
and 4-NQO. V364A, on the other hand was different from these
as it was resistant only to FLU and MTX while showed sensitivity
towards, CER, ANISO, CYH and 4-NQO. The mutant variant
P139A which behaved like WT-CaMdr1p-GFP was placed under
Class III (Figure 3). The spot assay results were confirmed by
microtiter assays as well. The MIC80 values of all these mutant
variants are listed in Table 1 and are the index of susceptibility in
the liquid medium.
Figure 2. Distribution curve of CRES values from the complete MSA. A: Histogram of the CRES scores for all positions of an MSA of DHA1 and
SP family. The 30 highest scoring CRES positions depicted in the marked region were selected for further analysis. B: The table shows 19 out of the 30
highest scoring CRES alignment positions wherein the CaMdr1p residue matched with the most frequent amino acid at that position in the MSA.
Their predicted location with respect to CaMdr1p is also displayed in the next column.
doi:10.1371/journal.pone.0011041.g002
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All the mutant variants of CaMdr1p are normally
expressed and properly localized
To confirm that the change in susceptibility of mutant
variants to various drugs was not due to their poor expression or
surface localization, we compared the surface expression and
localization of GFP-tagged version of CaMdr1p (CaMDR1-
GFP) and its mutant variants. Notwithstanding the fact that all
the mutant variants displayed decreased resistance to drugs,
their expression levels matched with that of WT-CaMdr1p-GFP
as confirmed by Western Blot Analysis (Figure 4A) while both
FACS and confocal imaging confirmed their proper surface
localization (rimmed appearance of GFP-tagged CaMdr1p)
(Figure 4B).
High CRES residues displayed abrogated efflux
To validate the drug susceptibility data of the mutant variants,
we conducted efflux measurements by employing three substrates,
fluorescent NR, and radiolabel [3H] FLU and [3H] MTX. All the
three compounds have been shown to be the substrates of
CaMdr1p [8], [17]. The intracellular concentration of these
substrates was determined with respect to time. It was observed
that there was minimum accumulation of substrates at 30 minutes.
Hence a time point of 30 minutes was selected for checking
intracellular accumulation of all these three substrates in the
mutant variants and then compared with host AD1-8u-. Notably,
the level of intracellular accumulation of [3H] FLU, [3H] MTX
and NR is indicative of high (low accumulation) or low (high
accumulation) efflux activity of the cell mediated by CaMdr1p.
Site-directed mutant variants of these high CRES positions showed
increased accumulation at 30 minutes as compared to that of WT-
CaMdr1p and thus indicating a decrease in their ability to efflux
NR, [3H] FLU and [3H] MTX. The increased accumulation of
NR and [3H] MTX in mutant variants D235A, G264L, P261A,
G133L, G472L, Y369A, G391L, G515L, F277A, L246A, S232A
and P257A, was attributed to the loss of efflux activity upon
mutation. All the other mutant variants which though exhibited
different levels of sensitivity to various drugs i.e. V364A, M132A,
A231G, P512A and V496A or which remained resistant to all
drugs i.e. P139A, continued to efflux these three substrates as
efficiently as WT-CaMdr1p. Exceptionally, S505A, which exhib-
ited differential sensitivity towards the drugs also showed
differential accumulation of these substrates. For example,
S505A displaying decreased accumulation in case of [3H] FLU
Figure 3. Drug susceptibility assay of mutant variants of CaMDR1-GFP. A: Drug resistance profile of wild type and mutant CaMDR1-GFP
yeast strains as determined by spot assay. 5 ml of five-fold serial dilutions, namely 1 (1:5), 2 (1:25), 3 (1:125) and 4 (1:625), of each strain was spotted on
to YEPD plates as described previously in the absence (control) and presence of the following drugs: FLU (0.20 mg/ml), MTX (65 mg/ml), CER (3 mg/ml),
ANISO (3 mg/ml), CYH (0.20 mg/ml) and 4-NQO (0.20 mg/ml). Growth differences were recorded following incubation of the plates for 48 hrs at 30uC.
Growth was not affected by the presence of the solvents used for the drugs (data not shown).
doi:10.1371/journal.pone.0011041.g003
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and [3H] MTX, showed no change in NR accumulation which
was comparable to AD1-8u- cells (Figure 5).
Discussion
CaMdr1p is one of the major MDR transporter involved in
frequently occurring azole resistance in C. albicans. The efflux
pump proteins display promiscuity towards substrate specificity
wherein a very large number of structurally diverse compounds
can be extruded by the transporter. In-depth knowledge of protein
structure and function is essential for any logical approach to block
the activity of such protein in MDR isolates of Candida. This study
represents an attempt in that direction wherein a rational
approach is applied to predict functionally critical amino acids
of this transporter. For this, we have employed information
theoretic measures which provide objectivity in scoring the
differentially conserved residues between two contrasting families
[18]. While it is intuitive to select these conserved residues across
the subfamily, by a visual analysis of a multiple alignment,
however, one tends to miss out the residues which may have a
lower conservation but still are functionally important. As
CaMdr1p is an antiporter and belongs to DHA1 family, we
contrasted DHA1 (antiporters) and SP family (symporters) to
identify residues differentially conserved between these two
families. We then scaled the CRE across the two families with
the conservation in DHA1 which helped us to enlist the alignment
positions on the basis of high CRE as well as high conservation
across the entire DHA1 family. This enabled us to identify residues
conserved exclusively in DHA1 and those which were differentially
conserved among the two families.
We selected thirty highest CRES scoring residues and further
short-listed those which were present in CaMdr1p. The 19 such
residues of CaMdr1p D235, G264, P261, G133, A231, G472,
V364, Y369, G391, G515, M132, F277, P139, L246, P512, S232,
S505, P257 and V496 were subjected to site-directed mutagenesis.
Our analysis revealed that all the mutant variants except P139A
displayed decreased resistance to the tested drugs though at
varying degree and specificity. This ranged from having twelve
mutant variants D235A, G264L, P261A, G133L, G472L, Y369A,
G391L, G515L, F277A, L246A, S232A and P257A showing
hypersensitivity to all the drugs, to six variants A231G, V364A
M132A, P512A, S505A and V496A which displayed loss in
resistance to only selective drugs. The efflux of MTX, FLU and
NR by mutant variants was abrogated which matched well with
the loss in drug resistance. We ensured that such changes were not
related to poor expression and surface localization of mutant
variant proteins (Figure 4).
We predict that the residues with high CRES scores will have a
role in drug-proton antiporter function of CaMdr1p. As the CRES
scores decrease, the residues might not turn out to be important
for drug-proton antiport function. CRES calculations also assign a
low score to residues which are identically conserved in both these
families. Such residues are shown to be MFS-wide-function-
specific in our previous study [8]. Thus, we hypothesize that
residues having high CRES score are critical for drug-proton
antiport function while residues with low CRES scores are not
expected to be critical for drug-proton antiport function but may
be important for family-wide function. For example, we have
earlier shown that residues G165, R215 and P296 are involved in
MFS-wide functions and this study shows that these residues have
low CRES scores. Thus, these residues are predicted to be critical
for MFS-wide functions such as inter-helical interactions but are
not involved directly in drug-proton antiport function of CaMdr1p
[8].
As an exception, our criteria of CRES also picked up two
residues D235 and F277, which were earlier reported to be family-
wide function-specific [8]. This could probably be because our
program does not discriminate between the nature of amino acid
present in DHA1 and SP families at a given alignment position.
Some positions that are scored using this method may be actually
excluded using our knowledge of amino acid similarity. For
example, at position 235 of CaMdr1p, an aspartate is present.
However, a glutamate occurs with same frequency at the
respective alignment position in the SP family. This has been
identified to be differentially conserved in DHA1 and SP. Another
exception, P139, though predicted to be important, failed to show
any effect when replaced with alanine.
Our study puts forward a list of residues important for DHA1,
drug-proton antiporters, when compared against SP, a symporter
family. Since functionally critical residues of CaMdr1p are
predicted to be DHA1 family specific, we validated this by
comparing observations from previously published studies. In
VAChT, a human vesicular acetylcholine transporter, a member
of DHA1 family, six glycine and proline rich motifs are predicted
to promote the formation of special backbone conformations
Table 1. MIC80 values of the mutant variants of CaMdr1p.
MIC80 (mg/ml)
STRAIN FLU MTX ANISO CER CYH 4-NQO
AD1-8u- 0.5 16 0.5 0.5 0.015 0.03
WT-CaMDR1-GFP 16 128 32 8 0.5 1.0
CLASS I
Residues in Antiporter motif
P261A 0.5 16 0.5 0.5 0.015 0.03
L246A 0.5 16 0.5 0.5 0.015 0.03
P257A 0.5 16 0.5 0.5 0.015 0.03
G264L 0.5 16 0.5 0.5 0.015 0.03
Other Residues
D235A 0.5 16 0.5 0.5 0.015 0.03
G133L 0.5 16 0.5 0.5 0.015 0.03
G472L 0.5 16 0.5 0.5 0.015 0.03
Y369A 0.5 16 0.5 0.5 0.015 0.03
G391L 0.5 16 0.5 0.5 0.015 0.03
G515L 0.5 16 0.5 0.5 0.015 0.03
F277A 0.5 16 0.5 0.5 0.015 0.03
S232A 0.5 16 0.5 0.5 0.015 0.03
CLASS II
A231G 8 64 8 4 0.125 0.06
M132A 4 64 32 4 0.125 0.03
P512A 8 64 4 4 0.125 0.06
V496A 8 64 16 2 0.125 0.06
S505A 8 64 0.5 4 0.03 0.06
V364A 4 32 2 1 0.03 0.03
CLASS III
P139A 16 128 32 8 0.5 1.0
The residues at high CRES positions were tested for their drug susceptibility and
their MIC80 (mg/ml) values are listed in comparison with the WT-CaMDR1-GFP
and AD1-8u- (Negative control). More than 2-well difference in Microtiter plates
was considered as significant, which matched with the results reported on the
solid medium in the spot assays [30].
doi:10.1371/journal.pone.0011041.t001
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including kinks in TMS, tight interactions between TMS and very
flexible b-turns. The hypothesized rocking motions in the MFS
family presumably require conformational changes in TMS and b-
turns which occur due to the presence of these kinks and notches
in the protein [19]. Interestingly, an analysis of the twelve mutant
variants of CaMdr1p which displayed complete sensitivity to all
the drugs, and also show abrogated efflux, reveals that most of
these are glycines and prolines. Taken together, it can be
hypothesized that these residues might be important for functions
such as proton-antiport, rocker-switch mechanism or drug binding
and translocation and if replaced, would result in a non-functional
protein displaying susceptibility to all the drugs. This high
propensity for kinks and notches are robustly predicted for motif
D2 (lgxxxxxPvxP), motif C (gxxxGPxxGGxl) and motif C’
(GxxxGPL). Interestingly, most of these nineteen residues of
CaMdr1p with high CRES turned out to be part of the well-known
motifs of the antiporters. These motifs are identified as Motif C
and Motif C’. It is known that the two halves of the protein must
have been formed due to a gene duplication event and thus Motif
C’ of C-terminal is degenerate as compared to Motif C of N-
terminal. Four out of the nineteen residues L246, P257, P261 and
G264 are a part of Motif C, a characteristic motif of the
antiporters [20], while residues S505, P512 and G515 are a part of
Motif C’. Their corresponding positions in VAChT, L214, S225,
P229 and G232 in Motif C and V420, P436 and A439 in Motif C’
are predicted to form a notch which allows two helical TMS to
approach each other closely because small side chains are located
at the interface. Motif D2 is located where it might help block non-
specific leakage of protons. It is known to hold a kink, which might
be involved in bend or swivel during conformational transitions,
also called as ‘‘molecular hinges’’. M132 and G133 of CaMdr1p
lie in this motif D2. Notably, different levels of sensitivity seen in
six other mutant variants A231G, V364A, M132A, P512A, S505A
and V496A points to the fact that even though there is a single
pore for proton antiport and drug binding and translocation, yet
there are residues which impart selectivity in drug recognition
along with those which affect the transport of all the drugs. Of
note, most of these residues with high CRES are located in or near
the pore in the 3D homology model of CaMdr1p, thus validating
their relevance (Figure 6). This 3D homology model was deduced
on the basis of crystal structures of MFS transporters such as lac
permease of E. coli (1pv6), glycerol-3-phophate of E. coli (1pw4)
and oxalate: formate transporter of O. formigenes (1zc7), as
described in our previous study [8]. The application of our
method to another MFS-MDR transporter EmrD of E. coli further
reveals that residues which are shown to be functionally critical
were found to have high CRES score and could be matched with
critical residues of CaMdr1p. For example, P257, P261 and S505
of CaMdr1p which correspond to P145, P149 and G340 of EmrD,
respectively, are predicted to be non-cavity lining residues as
explained by the known crystal structure of EmrD [21]. Thus, our
predictions are validated by CaMdr1p and may be extended
across the DHA1 family.
Conservation, RENULL and CRES are three different scores
which are routinely used to predict functionally critical residues of
a protein. Figure 7 shows a comparison among them and reveals
Figure 4. Expression profiles of CaMdr1p-GFP and its mutant variants. A: Western Blot analysis of the PM fraction of the mutant variants
with anti-GFP antibody. B: Confocal and FACS analysis of the all the mutant variants to check their expression and localization in comparison with
AD1-8u- (negative control) and WT-CaMDR1-GFP (positive control).
doi:10.1371/journal.pone.0011041.g004
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an interesting correlation. Traditional conservation, which uses
amino acid similarity, selects residues indiscriminately across the
transmembrane regions of the protein. These regions are
predominantly hydrophobic, as required for optimal positioning
within the hydrophobic environment of the lipid membrane.
RENULL helps in subtracting these background conservation
signals but can allow us to select only the residues which are
important for family-wide-function [8]. Discernible from the
Figure 7, is that the RENULL of DHA family is higher in the N-
terminal half as compared to the C-terminal half of the protein,
which supports the hypothesis that MFS proteins after duplication,
have concentrated family-wide-function specific residues in the N-
terminal half, while allowing divergence in the C-terminal half for
more specific function such as substrate binding and translocation
[6]. A comparison of an antiporter-specific alignment with a
symporter-specific alignment further helped us to subtract MFS
family-wide signals, so as to highlight residues, responsible for
antiporter specificity. From this differential comparison, a
concentration of signals around TMS 5-a known ‘‘antiporter
motif’’ is seen where residues are highlighted by the use of CRES
and this provides internal validation for the method. Other high-
scoring residues are distributed over both the N-terminal and the
C-terminal halves thus satisfying the earlier observation that
substrate specificity is contributed by residues in the C-terminal,
and providing a much sought after selection of novel residues,
which we predict are important for drug antiporter function. In
conclusion, we show that by using an information theoretic
measure, it is possible to rationally conduct structure and
functional study of a major MFS antiporter Mdr1p of Candida
albicans. The function-specific residues identified for the entire
DHA1 family are validated by CaMdr1p. These residues are
predicted to be responsible for subfamily-specific functions such as
drug binding and transport and proton translocation. Our analyses
predict that few residues in or around the pore differ on the basis
of the mechanism and substrate specificity of an MFS transporter
and are thus predicted to be specific for a particular subfamily.
Materials and Methods
Materials
Anti-GFP monoclonal antibody was purchased from BD
Biosciences Clontech, Palo Alto, CA, USA. DNA modifying
enzymes were purchased from NEB. The drugs cycloheximide
(CYH), 4-Nitroquinoline oxide (4-NQO), Methotrexate (MTX),
Cerulenin (CER), Anisomycin (ANISO), Nile Red (NR) and
Protease inhibitors (Phenylmethylsulfonyl fluoride, Leupeptin,
Aprotinin, Pepstatin A, TPCK, TLCK) and other molecular
grade chemicals were obtained from Sigma Chemicals Co. (St.
Louis, MO, USA). Fluconazole (FLU) was generously provided by
Ranbaxy Laboratories, India. [3H] Fluconazole was custom
prepared and [3H] Methotrexate (MTX) was purchased from
Amersham Biosciences, United Kingdom.
Media and Strains
Plasmids were maintained in Escherichia coli DH5a. E.coli was
cultured in Luria-Bertani medium (Difco, BD Biosciences, NJ,
USA) to which ampicillin was added (100 mg/ml). The Saccharo-
myces cerevisiae strain used was AD1-8u- (MATa pdr1-3 his1 ura3
Dyor1::hisG Dsnq2::hisG Dpdr5::hisG Dpdr10::hisG Dpdr11::hisG
Dycf1::hisG Dpdr3::hisG Dpdr15::hisG), provided by Richard D.
Figure 5. [3H] MTX and NR accumulation in the mutant variants of CaMdr1p-GFP. The graph shows accumulation levels of these substrates
relative to WT-CaMDR1-GFP. The grey colored bars (no border) indicate levels of accumulation for [3H] MTX while empty bars (black border) indicate
that for NR. Controls AD1-8u- and CaMdr1p-GFP have also been included for comparison. The accumulation assays with [3H] FLU gave similar results
as [3H] MTX for all the mutant variants (data not shown). The results are means 6 standard deviations for three independent experiments.
doi:10.1371/journal.pone.0011041.g005
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Cannon, University of Otago, Dunedin, New Zealand. The yeast
strains used in this study are listed in the Supplementary Data S3
[22], [23]. The yeast strains were cultured in YEPD broth (Bio101,
Vista, CA, USA) or in SD-ura- dropout media (0.67% yeast
nitrogen base, 0.2% dropout mix, and 2% glucose; Difco). For
agar plates, 2.5% (w/v) Bacto agar (Difco, NJ, USA) was added to
the medium.
Methods
Multiple Sequence Alignment (MSA). MFS sequences
belonging to DHA1 (Drug-Proton Antiporters Class I) and SP
(Sugar Porter) families were extracted from TCDB (http://www.
tcdb.org/index.php). The resultant dataset thus included 37
members of DHA1 and 44 members of SP. Redundant
sequences, if any, were identified using blastclust [24], by setting
the identity threshold S to 90, L to 0.9 and keeping all other
parameters to default values. The DHA1 and SP sequences were
then aligned separately by PRALINETM [25] using TMHMM
[26] as the method for predicting TM lengths and keeping all
other parameters at their default values. These resulting separate
DHA1 and SP PRALINETM alignments were then aligned
together by using the profile-profile alignment option of MUSCLE
[27]. Conservation of amino acids in a column, for the entire
dataset and for each family individually, was calculated using the
method described by Livingstone et al [28].
Calculation of Scaled Cumulative Relative Entropy
(CRES) score. Alignments for each of these two families were
extracted individually from the complete MSA. HMMbuild
program of HMMER (http://hmmer.wustl.edu) was used to
build profiles for these individual alignments. The probability of
occurrence of each amino acid is read from the HMM profiles, for
each alignment position and for both the subfamilies [29].
Relative Entropy (RE) is calculated as the deviation of the
amino acid distribution (for a particular column) of one subfamily
from that of another subfamily in the complete alignment. RE for
the two subfamilies y1 and y2 at column position i, is given by
Figure 6. The homology model of CaMdr1p highlighting the 3D location of the mutated residue positions. The 3D homology model of
CaMdr1p wherein the mutated positions are marked onto the model and are coloured on the basis of the phenotypes exhibited upon mutation.
Green denotes sensitive, red shows resistant while yellow marks those which exhibit differential sensitivity towards drugs upon mutation. The twelve
transmembrane segments (TMS) of CaMdr1p are numbered and are shown as a-helices. The pore is highlighted which clearly exhibits that the
mutated positions lie in or around the pore. The structure is viewed using pymol v0.99 (http://www.pymol.org).
doi:10.1371/journal.pone.0011041.g006
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REiy1 y2k ~
X
for all x
pi x,y1ð Þlog pi x,y1ð Þ
pi x,y2ð Þ
where, pi(x, yn) is the probability of the occurrence of amino acid
x in subfamily yn at column i of the MSA
RENULL for subfamily Y at column position i is given by
RENULL, i~
X
forall x
pi x,yð Þlog pi x,yð Þ
pNULL xð Þ
pNULL(x) is the background probability of the amino acid, based
on its occurrence in SWISSPROT. RENULL,i gives the conserva-
tion of column i with respect to the background probability
distribution of amino acids.
While CRE at column i is given by the Kullback-Liebler
distance between the corresponding ith columns
CREi~
X
for all x
pi x,y1ð Þlog pi x,y1ð Þ
pi x,y2ð Þz
X
for all x
pi x,y2ð Þlog pi x,y2ð Þ
pi x,y1ð Þ
" #
A classical description of entropy does not take into consider-
ation the absence of data points which are gaps in the case of a
multiple alignment column. Normalized CREi scores were
obtained using a scaling factor which is equal to number of
amino acid positions excluding gaps in column i divided by total
number of sequences [8].
To select the alignment positions on the basis of both, high
conservation across DHA1 and high CREi, the normalized CREi
was further scaled with respect to the RENULL as given by
Equation 2. This was referred to as CRES and represented as per
the following equation.
CRES~REnull  normalized?CREi
Figure 7. Comparative plot of Conservation, RENULL and CRES across the entire alignment. The three scores: Conservation in DHA1 family
(black), RENULL across DHA1 family (red) and CRES (green) are drawn as a line graph for all the alignment positions in the bottom panel of the Figure.
Locations of the TMS are marked by black bars on the x-axis. These twelve TMS are shown separately as an inset in the top panel so to highlight the
effectiveness of CRES over RE and traditional conservation. The conservation scores remain almost constant throughout the TMS while RENULL is more
prominent in the N-terminal half of the protein. High CRES positions span all the TMS, thus showing the functionally relevant residues to be scattered
over both the halves of the protein.
doi:10.1371/journal.pone.0011041.g007
ð1Þ
ð2Þ
ð3Þ
ð4Þ
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All calculations were made using PERL scripts, written in-house.
Site-directed mutagenesis of CaMdr1p. Site-directed
mutagenesis was performed by using the Quick-Change
Mutagenesis kit (Stratagene, La Jolla, CA, USA) as described
previously. The mutations were introduced into the plasmid
pRPCaMDR1-GFP according to the manufacturer’s instructions,
and the desired nucleotide sequence alterations were confirmed by
DNA sequencing of the ORF. The primers used for the purpose
are listed in Supplementary Data S4. The mutated plasmid, after
linearising with Xba1, was used to transform AD1-8u- cells for
uracil prototrophy by lithium acetate transformation protocol [4].
Integration was confirmed by Southern Blot analysis (data not
shown).
Drug Susceptibility. The susceptibilities of yeast cells,
harbouring wild type CaMDR1-GFP and its mutant variants,
was tested to different drugs by two independent methods:
microdilution assay (liquid medium) and spot assays (solid
medium). The MIC80 values for the strains were determined
with a broth microdilution method as described earlier [30]. For
spot assay, 5 ml samples of five-fold serial dilutions of yeast culture
each with cells suspended in normal saline to an OD600 of 0.1
(16106 cells) at A600 were spotted onto YEPD plates in the absence
(control) or in the presence of the drugs. Growth differences were
recorded following incubation of the plates for 48 hrs at 30uC.
Immunodetection of CaMdr1p and its mutant
variants. The plasma membranes (PM) were prepared from
S. cerevisiae cells, as described previously [4]. The PM protein
concentration was determined by bicinchonic acid assay using
bovine serum albumin as the standard. For Western Blot analysis,
the immunoblot was incubated with anti-GFP monoclonal
antibody (1:5000) (JL-8) (BD Biosciences) as described
previously. Immunoreactivity of GFP antibody was detected
using goat anti-mouse horseradish peroxidase-labelled antibody
(1:5,000) and was visualized using the enhanced
chemiluminescence assay system (ECL kit, Amersham
Biosciences, Arlington Heights, IL, USA) [4].
Transport of Nile Red. The accumulation of NR in cells
expressing WT or mutant variant CaMdr1p-GFP was measured
by flow cytometry with a FACSort flow cytometer (Becton-
Dickinson Immunocytometry Systems, San Jose, Calif.) [18].
Briefly 0.1 OD600 cells were inoculated and were incubated at
30uC with shaking until the cultures reached an OD600 of 0.25.
Cells were then harvested to be resuspended as 5% cell suspension
in diluted medium (containing one part YEPD and two parts
water). NR was added to a final concentration of 7 mM and cells
were incubated in shaking water bath at 150 rpm at 30uC for 30
minutes. The cells were then harvested, washed and then
resuspended in the diluted medium. Ten thousand cells were
analyzed in acquisition. Analysis was performed with CellQuest
software (Becton-Dickinson Immunocytometry Systems). The
mean fluorescence intensity was calculated using the histogram
stat program.
Transport of [3H] MTX and [3H] FLU. The accumulation
of [3H] MTX (specific activity, 8.60 Ci/mmol) and that of [3H]
FLU (specific activity, 19 Ci/mmol) was determined by protocol
described previously [8]. Cells from mid-log phase were
centrifuged at 5006 g for 3 min and resuspended in fresh
YEPD medium as 5% cell suspension. 100 ml of cell suspension
was incubated in shaking water bath at 150 rpm at 30uC and then
the radiolabelled drugs were added. The cells were incubated in
either [3H] MTX (25 mM) or [3H] FLU (100 nM) for 30 min,
filtered rapidly and washed twice with 1x PBS, pH 7.4 on
Millipore manifold filter assembly using 0.45 mm nitrocellulose
filter discs (Millipore, U.S.A). The filter discs were dried and put in
cocktail-O and the radioactivity was measured in a liquid
scintillation counter (Packard, Beckman, USA). The accu-
mulation was expressed relative to the WT- CaMDR1-GFP.
Supporting Information
Supplementary Data S1 The PRALINETM alignment of 34
sequences of DHA1 and 44 sequences of SP families as described
in Materials and Methods.
Found at: doi:10.1371/journal.pone.0011041.s001 (0.23 MB
PDF)
Supplementary Data S2 RE across DHA1 and SP families,
CRE and CRES scores for the entire MSA.
Found at: doi:10.1371/journal.pone.0011041.s002 (1.32 MB
DOC)
Supplementary Data S3 List of yeast strains used in this study.
Found at: doi:10.1371/journal.pone.0011041.s003 (0.05 MB
DOC)
Supplementary Data S4 List of oligonucleotides used for site-
directed mutagenesis.
Found at: doi:10.1371/journal.pone.0011041.s004 (0.06 MB
DOC)
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